RxDoctor Payments Data

Craig Sonke, MD

Family Medicine · Midland, MINPI 1215906052

Payments from drug & device makers

$1,122in general payments, 2019–2025

Across 80 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$250
  • Novo Nordisk$211
  • GSK$152
  • Boehringer Ingelheim$100
  • Astellas Pharma US Inc$71
  • AstraZeneca$50
  • plus $288 from 10 others

What the payments were for

  • Food & beverage$1,122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,122 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$36,001
Medicare patients
159
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$94,800
TrulicityDulaglutide51$72,819
EliquisApixaban72$70,954
JardianceEmpagliflozin37$57,203
JanuviaSitagliptin Phosphate29$45,713
MounjaroTirzepatide34$35,061
RybelsusSemaglutide28$29,552
FarxigaDapagliflozin Propanediol33$28,577
XareltoRivaroxaban25$24,982
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$17,458
Breo ElliptaFluticasone/Vilanterol18$8,829
Spiriva RespimatTiotropium Bromide17$8,508
Atorvastatin Calcium513$7,299
Repatha SureclickEvolocumab12$6,460
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$5,942

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$211$124,35283 claims
Lilly USA, LLCTrulicity, Mounjaro$11$107,88085 claims
PfizerEliquis$23$70,95472 claims
Boehringer IngelheimJardiance, Spiriva Respimat$100$65,71254 claims
AstraZenecaFarxiga, Symbicort$50$33,11150 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$152$31,89247 claims
Johnson & JohnsonXarelto$250$24,98225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Midland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →